5th Central and Eastern European Proteomic Conference (5th CEEPC)
Venue: Conference Centre U Hajku
|Event Date/Time: Sep 19, 2011||End Date/Time: Sep 22, 2011|
|Registration Date: Jun 30, 2011|
|Early Registration Date: May 20, 2011|
|Abstract Submission Date: Jun 30, 2011|
19th â€“ 22nd September 2011, Prague, Czech Republic
We are proposing to organise the 5th Central and Eastern European Proteomic Conference(CEEPC) in Prague, Czech Republic in September 2011. The successful series of CEEPC which has now become an established tradition, aims to bring together people interested in proteomics with special focus on the European regions where proteomics is not yet fully developed. Any funding from ESF FFG Programme would be channelled to facilitate mainly young scientists to attend this event as well as to invite scientific leaders in the field of proteomics to reach the desired goal. More information can be accessed from conference website at http://2011.czproteo.cz/.
A) Scientific Summary
Proteomics stands on a foundation laid by genomics. It is closely connected to transcriptomic studies, and provides a dynamic picture on molecular processes occurring in an organism. Biochemical pathways and signalling networks offer another examples of the interrelation of genetic and proteomic studies mainly in the area of biomedicine.
Proteomics, like other â€œomicsâ€, depends heavily on advanced technologies. Instrumentation is very expensive and needs substantial resources from individual countries. This is one of the prime reasons why the proteomics in former Central and Eastern European countries currently lags behind the US and Western Europe. Communication among laboratories in this region is sporadic, which also hinders development and coordination and which is also a stumbling block towards successful project grant applications. With these in mind, Czech scientists decided to launch a net-working conference the â€œCentral and Eastern European Proteomic Conferenceâ€ with the 1st meeting held in Prague in 2007 (http://2007.czproteo.cz/).
The aims of the 5th CEEPC are to disseminate information, help forming of stronger bonds and to promote collaboration among various laboratories. All important aspects of proteomics will be covered including advanced technologies and bioinformatics applied to biomedical and clinical applications. We strongly believe that medium-sized conferences, like CEEPC, rotating among various countries will stimulate and deepen research and collaboration. We are expecting approximately 120 attendees, among them fieldâ€“leading speakers from Europe and the US, senior and junior scientists, and of course young students â€“ the last two groups mainly from the European region. We have secured a list of key lecturers who will ensure a high level of scientific content (kindly see below).
The 5th Central and Eastern European Proteomic Conference will be organised in Prague, Czech Republic between 19th and 22nd September 2011. The main organiser is the Academy of Sciences of the Czech Republic, Institute of Animal Physiology and Genetics,v.v.i.. The meeting will be held at Conference Centre â€U HajkÅ¯â€ â€“ which provides ample space and conference related technical equipment as well as a friendly atmosphere at a reasonable price and near to the historical centre of the Prague. More information is avalable at conference web page at http://2011.czproteo.cz/.
H. KovÃ¡Å™ovÃ¡ Institute of Animal Physiology and Genetics, v.v.i., Academy of Sciences of the Czech Republic, LibÄ›chov
Suresh Jivan Gadher Institute of Animal Physiology and Genetics, v.v.i., Academy of Sciences of the Czech Republic, LibÄ›chov and Merck Millipore Scientific Advisor
AleÅ¡ SvatoÅ¡ Max Planck Institute for Chemical Ecology, Jena
Karoly Vekey Chemical Research Center, Hungarian Academy of Sciences, Budapest
GÃ¼nter Allmaier Institute of Chemical Technologies and Analytics, Vienna; University of Technology, Vienna
Details of venue
Conference Centre â€œU HajkÅ¯â€ (http://www.uhajku.cz/) is well equipped for medium-sized conferences: it has a large lecture hall, space for poster sections, and sufficient catering facilities for 150-200 participants. The hotel also offers 2 types of accommodation: standard (***) and superior (****). There are many other hotels and student dormitories in Prague which can be reached by public transport.
B) Draft Meeting Programme
We have put together an exciting program which will include plenary lectures, short presentations to be selected from abstract submissions as well as poster presentations. We hope to cover major fields of interest including:
1) Proteomic Diversity and Related fields:
1.1 Stem cell proteomics & cell therapy
Javier MuÃ±oz Peralta, Utrecht University,Utrecht, The Netherlands. Confirmed
1.2 Clinical proteomics & biomedical applications
David M. Lubman, University of Michigan Health Systems, Ann Arbor, USA
1.3 Plant proteomics & cytoskeletal proteins
Marek Å ebela, Palacky University, Olomouc, Czech Republic. Confirmed
1.3 Microbial proteomics and bioprocessing
Peter R. Jungblut, Max Planck Institute for Infection Biology, Berlin, Germany. Confirmed
Martina Marchetti-Deschmann, Vienna University of Technology, Vienna.
2) Structural and functional proteomics:
2.1Post-translational protein modifications & signalling pathways
Martin RÃ¸ssel Larsen, University of Southern Denmark, Odense, Denmark
2.2 Protein interactions & structure
Michal Dadlez, Polish Academy of Science, Warsaw, Poland
2.3 Proteome mining and Biological Systems
Michael Taussig, Babraham Bioscience Technologies, Cambridge, United Kingdom. Confirmed
Ravi Sirdeshmukh, Centre for Cellular and Molecular Biology, Hyderabad, India
3) Proteomic Technologies:
3.1 Novel mass spectrometry methodologies & outlook
Bernd Wollscheid, ETH, Curych, Switzerland. Confirmed
3.2 Data evaluation & bioinformatics
Javier De Las Rivas, University of Salamanca, Salamanca, Spain
Laszlo Drahos, Hungarian Academy of Sciences, Budapest, Hungary.Confirmed
3.3 Data verification & biomarker validation
Jennifer Van Eyk, Johns Hopkins University, Baltimore, USA
Alexander Archakov, Institute of Biomedical Chemistry, RAMS, Moscow, Russia.